Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 23 (PPIAP23)

Target
PPIAP23
Molecular classification
Other (Pseudogene)
01

Overview

Peptidylprolyl isomerase A pseudogene 23 (PPIAP23) is classified as a pseudogene, meaning it is a nonfunctional DNA segment that resembles the functional gene encoding peptidylprolyl isomerase A (PPIA)[1][5][6]. Pseudogenes usually arise by duplication or retrotransposition events, often acquiring disabling mutations such as frameshifts or premature stop codons that prevent protein expression[2][6]. PPIAP23 itself does not encode a functional protein and is not considered a direct therapeutic target, receptor, enzyme, or otherwise druggable entity[1][5][6]. Pseudogenes may sometimes regulate gene expression at the RNA level, but there is no evidence for a specific biological, biomarker, or disease role for PPIAP23 at this time[1][2][5][6]. Its primary function is as a genomic sequence homologous to the protein-coding PPIA gene (cyclophilin A), which is distinct and pharmacologically relevant, but PPIAP23 itself has no independent therapeutic or clinical significance.

Other names
PPIAP23

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 23 (PPIAP23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 23 (PPIAP23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call